Adaptive PVAB Shortening for Atrial Arrhythmia Detection in CRT Devices
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Implantable cardiac rhythm management devices equipped with multi-pole left ventricular leads face challenges in controlling cardiac resynchronization therapy (CRT) during atrial tachycardia, particularly due to the interference of long post-ventricular atrial refractory periods (PVAB) which can hinder the detection of organized atrial arrhythmias and lead to inappropriate mode switching.
Innovation Solution
The implementation of methods that allow the device to switch from multi-site left ventricular (MSLV) pacing to single-site LV pacing when the atrial rate exceeds a threshold, shortening the PVAB interval and enabling better recognition of organized atrial arrhythmias, and switching to a non-tracking mode above a higher threshold to detect atrial fibrillation, using rate stability and waveform morphology to discriminate between atrial rhythms.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If multi-site left ventricular (MSLV) pacing is used for CRT therapy, then cardiac resynchronization effectiveness is improved, but post-ventricular atrial refractory period (PVAB) is prolonged which hinders detection of organized atrial arrhythmias
Solution Approach 1:
The device dynamically adjusts the PVAB duration based on the detected atrial rhythm type. When organized atrial arrhythmia is detected, the PVAB is shortened to allow detection of subsequent atrial events. When sinus rhythm is detected, the PVAB is maintained at its longer duration to prevent FFRW oversensing. This dynamic adjustment resolves the contradiction by making the PVAB adaptive to different clinical conditions.
Solution Approach 2:
The invention changes the PVAB parameter (duration) based on the detected atrial rhythm characteristics. By monitoring atrial event regularity and rate, the system modifies the PVAB parameter to optimize both CRT effectiveness and arrhythmia detection capability, thus resolving the technical contradiction between maintaining long PVAB for CRT and shortening it for detection.
2Reliability
If long PVAB is maintained during MSLV pacing, then FFRW oversensing is prevented, but organized atrial arrhythmias cannot be detected
Solution Approach 1:
The system dynamically switches between two PVAB duration modes based on rhythm detection. In sinus rhythm mode, the long PVAB prevents FFRW oversensing. In organized atrial arrhythmia mode, the short PVAB enables detection of subsequent atrial events. This dynamic switching resolves the contradiction by applying the appropriate PVAB duration for each rhythm type.
Solution Approach 2:
The device uses feedback from atrial event detection to adjust PVAB duration. When organized atrial arrhythmia is detected through analysis of atrial event regularity and rate, the system feedback-adjusts the PVAB to a shorter duration to enable proper detection, thus resolving the contradiction between preventing oversensing and enabling detection.
3Measurement precision
If the device switches to non-tracking mode for atrial tachycardia detection, then atrial fibrillation detection is improved, but inappropriate mode switching may occur
Solution Approach 1:
The device performs preliminary analysis of atrial rhythm characteristics (regularity, rate, morphology) before switching to non-tracking mode. By preliminarily characterizing the atrial rhythm and comparing it against criteria for organized arrhythmia versus atrial fibrillation, the system ensures appropriate mode switching and prevents inappropriate transitions, thus resolving the contradiction between improved detection and appropriate switching.
Solution Approach 2:
The system dynamically selects the appropriate response mode (tracking vs. non-tracking) based on real-time analysis of atrial rhythm characteristics. This dynamic mode selection, guided by rhythm classification algorithms, ensures that non-tracking mode is activated only when appropriate for atrial fibrillation detection, preventing inappropriate mode switching while maintaining detection accuracy.
Data Source
AI summary
Systems and methods are provided for use by implantable medical devices equipped to deliver multi-site left ventricular (MSLV) pacing. MSLV is associated with a relatively long post-ventricular atrial blanking (PVAB) period that might limit the detection of pathologic rapid organized atrial tachycardias (OAT). In one example, MSLV cardiac resynchronization therapy (CRT) pacing is delivered within a tracking mode. A possible atrial tachycardia is detected based on the atrial rate exceeding an atrial tachycardia assessment rate (ATAR) threshold. The device then switches to single-site LV pacing, thereby effectively shortening the PVAB to detect additional atrial events that might otherwise be obscured, and thereby permitting the device to more reliably distinguish organized atrial tachycardias (such as atrial flutter) from sinus tachycardia. The device may also employ an automatic mode switch (AMS) threshold that is set higher than the ATAR threshold for use in switching from tracking modes to nontracking modes.